CLPT
Price:
$11.835
Market Cap:
$326.46M
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blac...[Read more]
Industry
Medical - Devices
IPO Date
2012-05-22
Stock Exchange
NASDAQ
Ticker
CLPT
According to ClearPoint Neuro, Inc.’s latest financial reports and current stock price. The company's current ROE is -62.10%. This represents a change of 284.08% compared to the average of -16.17% of the last 4 quarters.
The mean historical ROE of ClearPoint Neuro, Inc. over the last ten years is 476.73%. The current -62.10% ROE has changed -113.03% with respect to the historical average. Over the past ten years (40 quarters), CLPT's ROE was at its highest in in the December 2014 quarter at 1.91%. The ROE was at its lowest in in the September 2020 quarter at -995.46%.
Average
476.73%
Median
-74.58%
Minimum
-407.91%
Maximum
4.51%
Discovering the peaks and valleys of ClearPoint Neuro, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.25%
Maximum Annual ROE = 4.51%
Minimum Annual Increase = -111.52%
Minimum Annual ROE = -407.91%
Year | ROE | Change |
---|---|---|
2023 | -104.33% | 132.69% |
2022 | -44.83% | 42.78% |
2021 | -31.40% | -91.80% |
2020 | -383.17% | 170.22% |
2019 | -141.80% | -65.24% |
2018 | -407.91% | 231.72% |
2017 | -122.97% | -111.52% |
2016 | 1.07% | 150.27% |
2015 | 426.48% | -90.54% |
2014 | 4.51% | 4.25% |
The current ROE of ClearPoint Neuro, Inc. (CLPT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-60.19%
5-year avg
-141.11%
10-year avg
476.73%
ClearPoint Neuro, Inc.’s ROE is greater than Telesis Bio, Inc. (-184.13%), greater than AVITA Medical, Inc. (-28.99%), greater than Sight Sciences, Inc. (-47.28%), greater than Treace Medical Concepts, Inc. (-51.12%), greater than NeuroPace, Inc. (-205.41%), greater than Inogen, Inc. (-27.38%), greater than Surmodics, Inc. (-9.56%), greater than Pulmonx Corporation (-53.88%), greater than Apyx Medical Corporation (-156.40%), less than ProSomnus, Inc. Common Stock (50.75%), less than LivaNova PLC (1.88%), less than Electromed, Inc. (15.32%), greater than OrthoPediatrics Corp. (-7.64%), less than ShockWave Medical, Inc. (24.79%), greater than Inari Medical, Inc. (-17.75%), greater than Outset Medical, Inc. (-169.55%), less than Inspire Medical Systems, Inc. (5.30%), greater than Cytosorbents Corporation (-13069.04%), greater than TELA Bio, Inc. (-556.18%),
Company | ROE | Market cap |
---|---|---|
-184.13% | $1.62M | |
-28.99% | $349.74M | |
-47.28% | $203.53M | |
-51.12% | $487.79M | |
-205.41% | $289.53M | |
-27.38% | $223.42M | |
-9.56% | $561.12M | |
-53.88% | $268.12M | |
-156.40% | $54.40M | |
50.75% | $8.18M | |
1.88% | $2.79B | |
15.32% | $251.96M | |
-7.64% | $637.85M | |
24.79% | $12.57B | |
-17.75% | $2.91B | |
-169.55% | $44.01M | |
5.30% | $5.66B | |
-13069.04% | $50.31M | |
-556.18% | $118.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ClearPoint Neuro, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ClearPoint Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ClearPoint Neuro, Inc.'s ROE?
How is the ROE calculated for ClearPoint Neuro, Inc. (CLPT)?
What is the highest ROE for ClearPoint Neuro, Inc. (CLPT)?
What is the 3-year average ROE for ClearPoint Neuro, Inc. (CLPT)?
What is the 5-year average ROE for ClearPoint Neuro, Inc. (CLPT)?
How does the current ROE for ClearPoint Neuro, Inc. (CLPT) compare to its historical average?